Phase 3, Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Ustekinumab in Patients with Takayasu Arteritis.

Hajime Yoshifuji,Tomonori Ishii, Hiroki Ohashi, Katsunori Yoshizawa, Maki Mihoya, Kazuko Nishikawa,Yoshikazu Nakaoka

Rheumatology advances in practice（2025）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined